These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36163119)

  • 61. Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success.
    Michelozzi IM; Kirtsios E; Giustacchini A
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34198742
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy.
    Momparler RL; Côté S; Momparler LF
    Epigenomes; 2020 Mar; 4(1):. PubMed ID: 34968237
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
    Kikushige Y; Miyamoto T; Akashi K
    Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Leukemic stem cells shall be searched in the bone marrow before "tyrosine kinase inhibitor-discontinuation" in chronic myeloid leukemia.
    Ilhan O; Narli Ozdemir Z; Dalva K; Arslan A; Okay Ozgeyik M; Ipek S; Saydam G; Haznedaroglu IC
    Int J Lab Hematol; 2021 Oct; 43(5):1110-1116. PubMed ID: 33834631
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells.
    Reinisch A; Chan SM; Thomas D; Majeti R
    Semin Hematol; 2015 Jul; 52(3):150-64. PubMed ID: 26111462
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
    Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB
    Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment.
    Shah M; Bhatia R
    Adv Exp Med Biol; 2018; 1100():97-110. PubMed ID: 30411262
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
    Lim INX; Nagree MS; Xie SZ
    Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.
    Owen HC; Appiah S; Hasan N; Ghali L; Elayat G; Bell C
    Int Rev Neurobiol; 2017; 135():249-278. PubMed ID: 28807161
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
    Buettner R; Nguyen LXT; Morales C; Chen MH; Wu X; Chen LS; Hoang DH; Hernandez Vargas S; Pullarkat V; Gandhi V; Marcucci G; Rosen ST
    J Hematol Oncol; 2021 Apr; 14(1):70. PubMed ID: 33902674
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
    Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting the bone marrow microenvironment in acute leukemia.
    Karantanou C; Godavarthy PS; Krause DS
    Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.
    Thakral D; Gupta R; Khan A
    Stem Cell Rev Rep; 2022 Jun; 18(5):1756-1773. PubMed ID: 35412219
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species.
    Dou J; Li L; Guo M; Mei F; Zheng D; Xu H; Xue R; Bao X; Zhao F; Zhang Y
    Int J Nanomedicine; 2021; 16():1231-1244. PubMed ID: 33633448
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential niche and Wnt requirements during acute myeloid leukemia progression.
    Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
    Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
    Almohsen F; Al-Mudallal SS
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression.
    Urs AP; Goda C; Kulkarni R
    Ann Transl Med; 2024 Aug; 12(4):63. PubMed ID: 39118939
    [TBL] [Abstract][Full Text] [Related]  

  • 79. IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells.
    Zhang Y; Park M; Ghoda LY; Zhao D; Valerio M; Nafie E; Gonzalez A; Ly K; Parcutela B; Choi H; Gong X; Chen F; Harada K; Chen Z; Nguyen LXT; Pichiorri F; Chen J; Song J; Forman SJ; Amanam I; Zhang B; Jin J; Williams JC; Marcucci G
    J Hematol Oncol; 2024 Aug; 17(1):67. PubMed ID: 39143574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
    Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.